国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2009年
8期
563-565
,共3页
Survivin启动子%肿瘤%基因疗法
Survivin啟動子%腫瘤%基因療法
Survivin계동자%종류%기인요법
Survivin promoter%Neoplams%Gene therapy
利用特异性启动子介导的基因治疗是肿瘤靶向性治疗的一种有效途径.Survivin启动子既有肿瘤细胞的靶向性,又有增殖性血管内皮细胞的靶向性,且能有效介导目的基因表达,展示了其在肿瘤靶向性治疗研究中的良好前景.
利用特異性啟動子介導的基因治療是腫瘤靶嚮性治療的一種有效途徑.Survivin啟動子既有腫瘤細胞的靶嚮性,又有增殖性血管內皮細胞的靶嚮性,且能有效介導目的基因錶達,展示瞭其在腫瘤靶嚮性治療研究中的良好前景.
이용특이성계동자개도적기인치료시종류파향성치료적일충유효도경.Survivin계동자기유종류세포적파향성,우유증식성혈관내피세포적파향성,차능유효개도목적기인표체,전시료기재종류파향성치료연구중적량호전경.
Transcriptional targeting of gene therapy is a strategy for enhancing the specificity of gene expression to target tumor cells of interest. This targeting approach is based on the use of tissue-or tumor-specif-ic promoters(TSP) to direct the expression of therapeutic genes specifically to the tumor and not to relevant nor-mal tissue. Survivin promoter is one of the most promising promoter, which can target the tumor tissue as well as proliferating vascular endothelial cells. This article reviews the role of survivin promoter in tumor-targeting gene therapy.